Breaking News Instant updates and real-time market news.

AXP

American Express

$60.92

0.835 (1.39%)

, V

Visa

$82.50

0.92 (1.13%)

12:23
10/19/16
10/19
12:23
10/19/16
12:23

On The Fly: What to watch in credit card space earnings reports

American Express (AXP), Visa (V) and MasterCard (MA) are scheduled to report quarterly results on October 19, 24 and 28, respectively. What to watch for: 1. GUIDANCE: During its last earnings call, American Express said it expects 2016 adjusted earnings per share of $5.40-$5.70. "We are encouraged by progress so far this year and plan to continue spending at elevated levels during the remainder of 2016 in order to capitalize on the opportunities we see in a very competitive marketplace," the company added. Speaking during Visa's last quarter earnings call, the company's CFO Vasant Prabhu said he expects nominal net revenue growth in the fourth quarter for the legacy Visa business, not including Visa Europe, of around 5%-6%. Additionally, he sees Visa Europe adding 2%-3% to earnings per share accretion in 2017. Last month, MasterCard said it expects 2016 revenue to be up low double-digits and 2016 operating expense growth in low double-digits on currency-neutral basis. 2. COSTCO CARD: In an article published in August, Business Insider said that Costco (COST) still had members threatening to cancel over problems with the company's transition from American Express to Visa credit cards. Moreover, some members were said to be blaming Costco and Citi (C), which issues the credit cards, of not doing enough to fix the delays and confusion with the transition, the publication added. 3. PAYPAL PARTNERSHIPS: In July, PayPal (PYPL) and Visa announced a partnership to expand their relationship. PayPal would gain access to Visa's tokenization services for in-store PayPal transactions. Last month, the companies also announced that Visa Checkout would be available as a payment service for Braintree merchants. PayPal's Braintree offers solutions that enable merchants to accept a variety of payment options online, in app and in-stores. A few days later, PayPal and MasterCard announced an expansion of their partnership, with Mastercard becoming a payment option within PayPal and Masterpass a payment option for Braintree merchants. 4. ANALYSTS TAKE BEFORE RESULTS: Earlier this month, Nomura analyst Bill Carcache downgraded American Express to Reduce, saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. The third quarter is the first quarter that American Express will report excluding Costco, Carcache noted, adding that he thinks 2016 will mark the fourth year of market share losses in U.S. billings. Meanwhile, Deutsche Bank analyst Bryan Keane raised his price targets on Visa and MasterCard's shares to $103 and $124, respectively. The analyst expects accelerating growth to drive higher valuation multiples for the Payment Networks. Keane reiterated Buy ratings on both stocks. Last Monday, Pacific Crest analyst Josh Beck said that the end of Visa's fiscal 2016 should be "strong," highlighted by rock-solid Visa Europe execution and Costco strength." The analyst believes the stock "has real breakout potential," reiterating an Overweight rating and $92 price target on the shares.

AXP

American Express

$60.92

0.835 (1.39%)

V

Visa

$82.50

0.92 (1.13%)

MA

MasterCard

$102.46

0.725 (0.71%)

COST

Costco

$149.11

0.41 (0.28%)

C

Citi

$49.52

0.53 (1.08%)

PYPL

PayPal

$39.83

0.35 (0.89%)

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 14

    Nov

  • 16

    Nov

AXP American Express
$60.92

0.835 (1.39%)

09/09/16
ATLE
09/09/16
INITIATION
Target $62
ATLE
Underweight
American Express initiated with an Underweight at Atlantic Equities
Atlantic Equities initiated American Express with an Underweight and $62 price target.
09/09/16
09/09/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Express (AXP) initiated with an Underweight at Atlantic Equities. 2. Alcoa (AA) initiated with a Neutral at Seaport Global. 3. Blue Buffalo Pet Products (BUFF) initiated with an Outperform at Oppenheimer. 4. Harley-Davidson (HOG) initiated with an Outperform at Bernstein. 5. Verifone (PAY) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
NOMU
10/06/16
DOWNGRADE
Target $56
NOMU
Reduce
American Express downgraded to Reduce from Neutral at Nomura
Nomura analyst Bill Carcache downgraded American Express (AXP) to Reduce saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. The third quarter is the first quarter that American Express will report excluding Costco (COST), Carcache tells investors in a research note. He expects the "tug of war between bulls and bears to intensify" in Q3 and thinks 2016 will mark the fourth year of market share losses in U.S. billings. The analyst cut his price target for the shares to $56 from $62.
10/06/16
10/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Neutral from Buy at Goldman with analyst David Tamberrino saying he sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. 2. JPMorgan (JPM) downgraded to Hold from Buy at Sandler O'Neill with analyst Jeffery Harte citing relative share outperformance. 3. Abercrombie & Fitch (ANF) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jessica Schmidt saying the elevated promotions add to other headwinds, including the fact that the teen space is "overstored" and faces soft consumer demand and weak tourism. 4. American Express (AXP) downgraded to Reduce from Neutral at Nomura with analyst Bill Carcache saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. 5. Lowe's (LOW) downgraded to Neutral from Buy at Cleveland Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
V Visa
$82.50

0.92 (1.13%)

10/17/16
PACS
10/17/16
NO CHANGE
PACS
Visa should be bought at current levels, says Pacific Crest
Pacific Crest analyst Josh Beck says that the end of Visa's fiscal 2016 should be "strong," highlighted by rock-solid Visa Europe execution and Costco strength." The analyst thinks that the stock "has real breakout potential." He keeps a $92 price target and Overweight rating on the shares.
10/05/16
BERN
10/05/16
NO CHANGE
BERN
Market Perform
Bernstein lays out six possible strategic outcomes for PayPal
After hosting a call to discuss PayPal's (PYPL) strategic options following its recently announced deals with Visa (V) and MasterCard (MA), Bernstein analyst Lisa Ellis laid out the potential strategic outcomes for PayPal that she foresees. In order from most to least likely: the most likely outcome PayPal's business model remains but that it shifts to debit centric vs. ACH; it is less likely, but a risk, that PayPal becomes a merchant acquirer; even less likely is that PayPal becomes a closed-loop. The chance that PayPal is acquired is "unlikely but less so" after the deals with the card majors, Ellis added. Lastly, she sees a "low probability" PayPal withers away or that it morphs into something else via acquisition. The firm has a Market Perform rating on PayPal shares.
10/17/16
DBAB
10/17/16
NO CHANGE
Target $103
DBAB
Buy
Deutsche ups price targets for Visa, MasterCard
Deutsche Bank analyst Bryan Keane expects accelerating growth to drive higher valuation multiples for the Payment Networks. The analyst raised his price target for Visa (V) to $103 from $87 and for MasterCard (MA) to $124 from $104. Keane keeps Buy ratings on both stocks.
10/18/16
OPCO
10/18/16
NO CHANGE
Target $43
OPCO
Outperform
Oppenheimer remains bullish on PayPal ahead of results
Oppenheimer analyst Glenn Greene remains attracted to PayPal's (PYPL) "unique" digital payments assets, including Braintree, Venmo, Xoom, and "impressive" growth profile. Further, the analyst says that some of his previous concerns about the company's long-term competitive positioning have been allayed by the recent Visa (V)/MasterCard (MA) partnerships. Greene reiterates an Outperform rating and $43 price target on PayPal's shares.
MA MasterCard
$102.46

0.725 (0.71%)

09/08/16
JEFF
09/08/16
NO CHANGE
Target $48
JEFF
Buy
Jefferies says PayPal concerns over MasterCard deal overdone
After surveying 1,000 PayPal (PYPL) users, Jefferies analyst Jason Kupferberg believes the migration from ACH to card-funded transactions will likely be limited and gradual. The recent network partnerships will weigh on Paypal's transaction margins, but increased choice should lead to increased usage, Kupferberg tells investors in a research note. He believes concerns over the MasterCard (MA) deal are overdone and keeps a Buy rating on PayPal with a $48 price target.
COST Costco
$149.11

0.41 (0.28%)

10/19/16
NRCS
10/19/16
UPGRADE
NRCS
Buy
Costco upgraded to Buy from Neutral at Northcoast
10/18/16
10/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Market Perform at Wells Fargo. 2. Level 3 (LVLT) initiated with an Overweight at Barclays. 3. AC Immune (ACIU) initiated with a Buy at Jefferies, an Outperform at Credit Suisse, and an Outperform at Leerink. 4. Apptio (APTI) initiated with a Neutral at Goldman, a Buy at Jefferies, an Equal Weight at Barclays, a Neutral at JPMorgan, a Buy at BofA/Merrill, an Overweight at Pacific Crest, and a Sector Perform at RBC Capital. 5. Adient (ADNT) initiated with an Outperform at Baird, a Neutral at Buckingham, and a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/16
10/19/16
UPGRADE

Buy
Costco upgraded to Buy on earnings momentum at Northcoast
As previously reported, Northcoast upgraded Costco to Buy from Neutral with a $175 price target. Analyst Chuck Cerankosky expects a stronger earnings improvement in 2018 and believes the performance will reflect a $5 membership increase in the US and Canada. Further, the analyst expects the board to declare another $5 per share special dividend given the company's strong cash flow and for the company to benefit from the new relationship with Visa.
10/19/16
10/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Hold from Sell at Loop Capital with analyst Blake Harper saying downside is limited, even if the Q3 results disappoint, as there is "essentially a floor on the value of shares given the M&A speculation." 2. Costco (COST) upgraded to Buy from Neutral at Northcoast with analyst Chuck Cerankosky saying he expects a stronger earnings improvement in 2018 and believes the performance will reflect a $5 membership increase in the US and Canada. 3. Yum! Brands (YUM) upgraded to Outperform from Neutral at Credit Suisse with analyst Jason West citing a bullish outlook for the "New Yum" non-China, which will begin to trade on a standalone basis on November 1. 4. America's Car-Mart (CRMT) upgraded to Buy from Underperform at BofA/Merrill with analyst Elizabeth Suzuki saying she believes competition in the subprime auto market is beginning to ease and said she is seeing signs of credit tightening at other subprime lenders which should benefit Car-Mart. 5. Alon USA Partners (ALDW) and Western Refining (WNR) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$49.52

0.53 (1.08%)

10/11/16
COMP
10/11/16
INITIATION
Target $39
COMP
Sell
Citi initiated with a Sell at Compass Point
Compass Point analyst Charles Peabody initiated Citi with a Sell and a $39 price target saying earnings continue to look week combined with soft international and capital markets.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
GSCO
09/16/16
DOWNGRADE
GSCO
Neutral
Citi downgraded to Neutral from Buy at Goldman
Goldman analyst Richard Ramsden downgraded Citi to Neutral and lowered his price target on the shares to $50 from $52. The analyst said Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. Ramsden's analysis suggests growth in higher return businesses, such as credit cards and wealth management, and expense discipline will not be enough to increase ROE all the way to its 10% target. Citi remains a capital returns story, constrained by the utilization of deferred tax assets, the analyst wrote in his report.
PYPL PayPal
$39.83

0.35 (0.89%)

10/11/16
JEFF
10/11/16
NO CHANGE
Target $48
JEFF
Buy
PayPal Q3 results could be positive catalyst, says Jefferies
Jefferies analyst Jason Kupferberg believes PayPal's Q3 results on October 20 would be a positive catalyst for the shares. The analyst expects a "solid" quarter and still views PayPal as the best way to play digital/online payments. He keeps a Buy rating on the shares with a $48 price target.
10/18/16
EVER
10/18/16
INITIATION
Target $46
EVER
Buy
PayPal coverage transferred with a Buy at Evercore ISI
Evercore ISI analyst David Togut assumed coverage on PayPal with a Buy rating and a $46 price target.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$52.42

-0.26 (-0.49%)

08:00
02/22/17
02/22
08:00
02/22/17
08:00
Upgrade
VF Corp. rating change  »

VF Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$57.60

3.7 (6.86%)

, PLKI

Popeyes

$78.73

12.61 (19.07%)

07:56
02/22/17
02/22
07:56
02/22/17
07:56
Recommendations
Restaurant Brands, Popeyes analyst commentary  »

Restaurant Brands…

QSR

Restaurant Brands

$57.60

3.7 (6.86%)

PLKI

Popeyes

$78.73

12.61 (19.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Mar

ARGS

Argos Therapeutics

$4.40

-0.3 (-6.38%)

07:55
02/22/17
02/22
07:55
02/22/17
07:55
Hot Stocks
Breaking Hot Stocks news story on Argos Therapeutics »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Apr

GS

Goldman Sachs

$251.76

1.38 (0.55%)

07:55
02/22/17
02/22
07:55
02/22/17
07:55
Initiation
Goldman Sachs initiated  »

Goldman Sachs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

RDS.A

Royal Dutch Shell

$52.49

0.29 (0.56%)

07:55
02/22/17
02/22
07:55
02/22/17
07:55
Conference/Events
Royal Dutch Shell to hold a conference call »

EVP of Gas and Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ACRX

AcelRx

$3.15

0.05 (1.61%)

, CBM

Cambrex

$54.90

0.55 (1.01%)

07:55
02/22/17
02/22
07:55
02/22/17
07:55
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

ACRX

AcelRx

$3.15

0.05 (1.61%)

CBM

Cambrex

$54.90

0.55 (1.01%)

CRIS

Curis

$2.66

-0.02 (-0.75%)

ESPR

Esperion

$24.42

-0.58 (-2.32%)

DVAX

Dynavax

$3.95

-0.05 (-1.25%)

FLXN

Flexion

$19.66

0.43 (2.24%)

GILD

Gilead

$69.29

-0.56 (-0.80%)

CURE

Curative Health Services Inc

$33.80

0.45 (1.35%)

PCRX

Pacira

$44.15

0.45 (1.03%)

NVDQ

Novadaq

$6.76

0.17 (2.58%)

AXON

Axovant Sciences

$12.11

-0.03 (-0.25%)

TSRO

TESARO

$190.27

-0.09 (-0.05%)

EGRX

Eagle Pharmaceuticals

$73.59

-0.53 (-0.72%)

LPNT

LifePoint

$65.15

1.25 (1.96%)

PRTA

Prothena

$55.00

-0.22 (-0.40%)

ABEO

Abeona Therapeutics

$5.25

-0.75 (-12.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 02

    Mar

  • 06

    Mar

  • 17

    Mar

  • 21

    Mar

  • 01

    Apr

  • 27

    Apr

  • 30

    Jun

  • 06

    Oct

MS

Morgan Stanley

$46.56

0.41 (0.89%)

07:54
02/22/17
02/22
07:54
02/22/17
07:54
Initiation
Morgan Stanley initiated  »

Morgan Stanley initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:53
02/22/17
02/22
07:53
02/22/17
07:53
Conference/Events
Forecasters Club of New York to hold a luncheon meeting »

Federal Reserve Governor…

USPH

U.S. Physical Therapy

$76.10

2 (2.70%)

07:52
02/22/17
02/22
07:52
02/22/17
07:52
Conference/Events
CFA Society of Houston to hold a luncheon meeting »

Chris Reading, CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 21

    Mar

  • 29

    Mar

  • 11

    Apr

  • 12

    Apr

SOHO

Sotherly Hotels

$7.04

-0.4 (-5.38%)

07:51
02/22/17
02/22
07:51
02/22/17
07:51
Recommendations
Sotherly Hotels analyst commentary  »

Sotherly Hotels can still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$45.60

-0.02 (-0.04%)

07:49
02/22/17
02/22
07:49
02/22/17
07:49
Initiation
Glaukos initiated  »

Glaukos initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

DBD

Diebold

$29.70

-0.4 (-1.33%)

07:48
02/22/17
02/22
07:48
02/22/17
07:48
Initiation
Diebold initiated  »

Diebold initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FSLR

First Solar

$36.62

1.78 (5.11%)

07:45
02/22/17
02/22
07:45
02/22/17
07:45
Downgrade
First Solar rating change  »

First Solar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$126.34

1.07 (0.85%)

07:45
02/22/17
02/22
07:45
02/22/17
07:45
Hot Stocks
Aetna announces $3.3B accelerated share repurchase »

Aetna announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:43
02/22/17
02/22
07:43
02/22/17
07:43
Conference/Events
CFA Society of Washington, D.C. to hold a luncheon discussion »

The CFA Society of…

CSCO

Cisco

$34.13

0.39 (1.16%)

07:43
02/22/17
02/22
07:43
02/22/17
07:43
Recommendations
Cisco analyst commentary  »

Cisco at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

M

Macy's

$32.29

-0.01 (-0.03%)

07:43
02/22/17
02/22
07:43
02/22/17
07:43
Recommendations
Macy's analyst commentary  »

Macy's risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

NVIDIA

$111.07

3.84 (3.58%)

07:43
02/22/17
02/22
07:43
02/22/17
07:43
Initiation
NVIDIA initiated  »

NVIDIA initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

  • 16

    Mar

EYEG

EyeGate

$3.70

2.0601 (125.62%)

07:42
02/22/17
02/22
07:42
02/22/17
07:42
Syndicate
Breaking Syndicate news story on EyeGate »

EyeGate files $3.29M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCN

Welltower

$66.94

1.02 (1.55%)

07:42
02/22/17
02/22
07:42
02/22/17
07:42
Hot Stocks
Welltower enters into strategic collaboration with Johns Hopkins Medicine »

Welltower announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

  • 01

    Mar

HD

Home Depot

$145.02

2.02 (1.41%)

07:42
02/22/17
02/22
07:42
02/22/17
07:42
Recommendations
Home Depot analyst commentary  »

Home Depot guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

AMD

AMD

$14.00

0.87 (6.63%)

07:41
02/22/17
02/22
07:41
02/22/17
07:41
Initiation
AMD initiated  »

AMD initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

QSR

Restaurant Brands

$57.60

3.7 (6.86%)

, PLKI

Popeyes

$78.73

12.61 (19.07%)

07:41
02/22/17
02/22
07:41
02/22/17
07:41
Recommendations
Restaurant Brands, Popeyes analyst commentary  »

Oppenheimer sees…

QSR

Restaurant Brands

$57.60

3.7 (6.86%)

PLKI

Popeyes

$78.73

12.61 (19.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Mar

SBGI

Sinclair Broadcast

$36.90

0.4 (1.10%)

07:40
02/22/17
02/22
07:40
02/22/17
07:40
Hot Stocks
Sinclair Broadcast sees FY17 barter and trade revenue $116M »

Consensus for FY17 total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

CHS

Chico's

$14.29

0.27 (1.93%)

07:40
02/22/17
02/22
07:40
02/22/17
07:40
Hot Stocks
Chico's reports Q4 gross margin 35.5% vs. 34.4% a year ago »

When excluding Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.